Lymphocytes play vital roles in the mammalian immune system. In adult organisms, these cells arise, via a step-bystep differentiation process, from hematopoietic stem cells (HSCs) residing mainly in the bone marrow. This process has been well studied and is a paradigm of cell differentiation by which primitive and multipotent cells acquire specific functions and locations. It has been demonstrated that various cytokines, cell-surface molecules, and transcription factors serve synergistically and hierarchically to constitute the exquisite mechanism of lymphopoiesis. However, an important question remains: how are these diverse elements harmonized and orchestrated?
While cytokine signaling and transcription factors have long been a topic of investigation, molecular mechanisms of lymphopoiesis are now being studied extensively in terms of epigenetic regulation and microRNAs. In this issue, four review articles by expert investigators in this field present up-to-date findings from continuous studies ( Fig. 1 ) to Progress In Hematology readers.
The transcription factor Ikaros has been extensively studied as an essential regulator of the early stages of lymphocyte differentiation. Recent studies have revealed that Ikaros is actively involved in a broad range of lymphocyte differentiation processes. The protein has further attracted much attention as an integral component connecting the transcription complex and chromatin-remodeling network. Yoshida and Georgopoulos, leading scientists and pioneers of research on Ikaros, present a comprehensive review on how this protein promotes normal lymphopoiesis and prevents leukemogenesis [1] .
Lymphocyte differentiation requires both activation of lymphoid-related genes and inactivation of other lineagerelated genes. It is now appreciated that the early stages of lymphopoiesis proceed from a heterogeneous population of HSCs through asynchronous pathways of gene expression. However, there seems to be a fundamental mechanism that directs HSCs toward the lymphoid lineage by orchestrating the expression of various genes. Yokota and Kanakura introduce global chromatin-remodeling proteins, particularly Special AT-rich sequence-binding protein 1 (Satb1), as important regulators of early lymphocyte differentiation [2] .
Lymphocytes are endowed with a special gene recombination ability to overcome diverse pathogens. While recombination of the immunoglobulin gene or the T cell receptor genes is vital to the adaptive immune system, the process increases the risk of mutation by introduction of double-strand DNA breaks. Shimazaki and Lieber, who have made a remarkable contribution to the understanding of gene recombination mechanisms in lymphopoiesis, present recent findings on the elaborate control of recombination by chromatin structure and histone modification [3] .
Since the discovery of micro RNAs (miRNAs), a wealth of information validating their biological significance has accumulated. It is now known that many miRNAs are expressed in HSCs and lymphoid progenitors. However, in recent years, studies on microRNAs have shed new insights on the molecular control of lymphopoiesis. Chong and his colleagues, experts on miRNA biogenesis and miRNA function in the T cell lineage, summarize the functional significance of miRNAs not only in lymphoid-lineage cells but also in HSCs and dendritic cells [4] .
These four reviews present and discuss a large amount of information from different points of view. All the mechanisms discussed are intimately associated with each other to maintain normal lymphopoiesis and to evade hematopoietic malignancy. I believe that this Progress In Hematology series will help us to develop more sophisticated strategy to control lymphopoiesis.
